22nd Century Group, Inc. (XXII) is a Tobacco company in the Consumer Defensive sector, listed on Nasdaq.
This page provides the complete earnings calendar, dividend schedule, and financial data for 22nd Century Group, Inc. in 2026. The next earnings report is expected on November 10, 2026.
22nd Century Group, Inc. missed consensus estimates in its latest earnings report, with an EPS loss of $15.60 versus an expected loss of $6.00 and revenue of $2.86 million falling 61.7% short of expectations. In the prior quarter, both EPS and revenue also missed expectations.
Dividend calendar
No dividend history available.
EPS (Earnings Per Share)
Revenue
Company profile
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
